ELBL, Lubomír, Hana HRSTKOVÁ, Iva TOMÁŠKOVÁ, Bohumír BLAŽEK and Jaroslav MICHÁLEK. Long-term serial echocardiographic examination of late anthracycle cardiotoxicity and its prevention by dexrazoxane in pediatric patients. Eur J Pediatr. 2005, vol. 164, No 11, p. 678-684. ISSN 0340-6199.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Long-term serial echocardiographic examination of late anthracycle cardiotoxicity and its prevention by dexrazoxane in pediatric patients.
Name in Czech Dlouhodobé echokardiografické sledování pozdní kardiotoxicity a její prevence dexrazoxanem u dětských pacientů.
Name (in English) Long-term serial echocardiographic examination of late anthracycle cardiotoxicity and its prevention by dexrazoxane in pediatric patients.
Authors ELBL, Lubomír (203 Czech Republic, guarantor), Hana HRSTKOVÁ (203 Czech Republic), Iva TOMÁŠKOVÁ (203 Czech Republic), Bohumír BLAŽEK (203 Czech Republic) and Jaroslav MICHÁLEK (203 Czech Republic).
Edition Eur J Pediatr, 2005, 0340-6199.
Other information
Original language Czech
Type of outcome Article in a journal
Field of Study 30201 Cardiac and Cardiovascular systems
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 1.382
RIV identification code RIV/00216224:14110/05:00014859
Organization unit Faculty of Medicine
UT WoS 000232695900005
Keywords in English Late cardiotoxicity; pediatric cancer; echocardiography; dexrazoxane
Tags dexrazoxane, Echocardiography, Late cardiotoxicity, pediatric cancer
Changed by Changed by: prof. MUDr. Petr Kala, Ph.D., učo 2263. Changed: 7/2/2006 16:15.
Abstract
Eight-year follow-up by means of serial echocardiographic investigation demonstrated lower presence of impaired left ventricular function in patients treated with anthracyclines and cardioprotective drug dexrazoxane compared to patients without cardioprotection.
Abstract (in English)
Eight-year follow-up by means of serial echocardiographic investigation demonstrated lower presence of impaired left ventricular function in patients treated with anthracyclines and cardioprotective drug dexrazoxane compared to patients without cardioprotection.
Links
MSM0021622402, plan (intention)Name: Časná diagnostika a léčba kardiovaskulárních chorob
Investor: Ministry of Education, Youth and Sports of the CR, Early diagnostics and treatment of cardiovascular diseases
PrintDisplayed: 31/5/2024 03:43